CycB/CCNB1 Cancer Research Results

CycB/CCNB1, Cyclin B: Click to Expand ⟱
Source:
Type:
When cyclin B levels are elevated, cells can enter M phase prematurely and strict control over cell division is lost, which is favorable for cancer development.
Cyclin B is a regulatory protein that plays a crucial role in cell cycle progression, particularly in the transition from the G2 phase to mitosis. Its expression levels can significantly impact cancer progression and patient prognosis.
Cyclin B expression is often elevated in various cancers and is generally associated with poor prognosis.
Cyclin B levels:
-Accumulate during S and G2
-Peak at mitotic entry
-Are rapidly destroyed at metaphase–anaphase transition via the APC/C ubiquitin ligase


Cerv, Cervical Cancer: Click to Expand ⟱
Cervical Cancer

Scientific Papers found: Click to Expand⟱
1145- CHr,    Chrysin inhibits propagation of HeLa cells by attenuating cell survival and inducing apoptotic pathways
- in-vitro, Cerv, HeLa
tumCV↓, BAX↑, BID↑, BOK↑, APAF1↑, TNF-α↑, FasL↑, Fas↑, FADD↑, Casp3↑, Casp7↑, Casp8↑, Casp9↑, Mcl-1↓, NAIP↓, Bcl-2↓, CDK4↓, CycB/CCNB1↓, cycD1/CCND1↓, cycE1↓, TRAIL↑, p‑Akt↓, Akt↓, mTOR↓, PDK1↓, BAD↓, GSK‐3β↑, AMPK↑, p27/CDKN1B↑, P53↑,
477- CUR,    Curcumin induces G2/M arrest and triggers autophagy, ROS generation and cell senescence in cervical cancer cells
- in-vitro, Cerv, SiHa
TumCP↓, TumCCA↑, Apoptosis↑, TumAuto↑, CycB/CCNB1↓, CDC25↓, ROS↑, p62↑, LC3‑Ⅱ/LC3‑Ⅰ↑, cl‑Casp3↑, cl‑PARP↑, P53↑, P21↑,
7103- GEN,    A Comprehensive Review of Genistein's Effects in Preclinical Models of Cervical Cancer
- Review, Cerv, NA
TumCP↓, Apoptosis↑, RadioS↑, ChemoSen↑, *antiOx↑, *Inflam↓, *Bacteria↓, *AntiViral↑, *AntiDiabetic↑, *neuroP↑, AntiCan↑, TumCG↓, TumCI↓, TumCCA↑, cl‑PARP↑, selectivity↑, CycB/CCNB1↓, CDK1↓, p‑cDC2↓, p‑ERK↓, p‑p38↑, p‑JNK↑, MMP9↓, TIMP1↑, BioAv↓, BioAv↑, Half-Life↑,

Showing Research Papers: 1 to 3 of 3

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 3

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress(tgid=1)

ROS↑, 1,  

Mitochondria & Bioenergetics(tgid=3)

BOK↑, 1,   CDC25↓, 1,  

Core Metabolism/Glycolysis(tgid=4)

AMPK↑, 1,   PDK1↓, 1,  

Cell Death(tgid=5)

Akt↓, 1,   p‑Akt↓, 1,   APAF1↑, 1,   Apoptosis↑, 2,   BAD↓, 1,   BAX↑, 1,   Bcl-2↓, 1,   BID↑, 1,   Casp3↑, 1,   cl‑Casp3↑, 1,   Casp7↑, 1,   Casp8↑, 1,   Casp9↑, 1,   FADD↑, 1,   Fas↑, 1,   FasL↑, 1,   p‑JNK↑, 1,   Mcl-1↓, 1,   NAIP↓, 1,   p27/CDKN1B↑, 1,   p‑p38↑, 1,   TRAIL↑, 1,  

Transcription & Epigenetics(tgid=7)

tumCV↓, 1,  

Autophagy & Lysosomes(tgid=9)

LC3‑Ⅱ/LC3‑Ⅰ↑, 1,   p62↑, 1,   TumAuto↑, 1,  

DNA Damage & Repair(tgid=10)

P53↑, 2,   cl‑PARP↑, 2,  

Cell Cycle & Senescence(tgid=11)

CDK1↓, 1,   CDK4↓, 1,   CycB/CCNB1↓, 3,   cycD1/CCND1↓, 1,   cycE1↓, 1,   P21↑, 1,   TumCCA↑, 2,  

Proliferation, Differentiation & Cell State(tgid=12)

p‑cDC2↓, 1,   p‑ERK↓, 1,   GSK‐3β↑, 1,   mTOR↓, 1,   TumCG↓, 1,  

Migration(tgid=13)

MMP9↓, 1,   TIMP1↑, 1,   TumCI↓, 1,   TumCP↓, 2,  

Immune & Inflammatory Signaling(tgid=16)

TNF-α↑, 1,  

Drug Metabolism & Resistance(tgid=21)

BioAv↓, 1,   BioAv↑, 1,   ChemoSen↑, 1,   Half-Life↑, 1,   RadioS↑, 1,   selectivity↑, 1,  

Functional Outcomes(tgid=23)

AntiCan↑, 1,  
Total Targets: 57

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1)

antiOx↑, 1,  

Immune & Inflammatory Signaling(tgid=16)

Inflam↓, 1,  

Functional Outcomes(tgid=23)

AntiDiabetic↑, 1,   neuroP↑, 1,  

Infection & Microbiome(tgid=24)

AntiViral↑, 1,   Bacteria↓, 1,  
Total Targets: 6

Scientific Paper Hit Count for: CycB/CCNB1, Cyclin B
1 Chrysin
1 Curcumin
1 Genistein (soy isoflavone)
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:29  Cells:%  prod#:%  Target#:379  State#:%  Dir#:1
wNotes=0 sortOrder:rid,rpid

 

Home Page